STOCK TITAN

Senseonics Holdings, Inc. to Participate in the Gilmartin Group Emerging Growth Company Showcase

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences acquisition
Rhea-AI Summary
Senseonics Holdings, Inc. to present at Gilmartin Group Emerging Growth Company Showcase
Positive
  • None.
Negative
  • None.

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Gilmartin Group Emerging Growth Company Showcase, taking place virtually.

Management is scheduled to present on Thursday, September 21, 2023 from 11:30 a.m. to 11:55 a.m. ET. Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.

About Senseonics

Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems, Eversense®, Eversense® XL and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

Investor Contact

Philip Taylor

Gilmartin Group

415-937-5406

Investors@senseonics.com

Source: Senseonics Holdings, Inc.

Senseonics Holdings, Inc.

NYSE:SENS

SENS Rankings

SENS Latest News

SENS Stock Data

198.92M
581.29M
7.03%
11.01%
9.09%
Medical Devices
Industrial Instruments for Measurement, Display, and Control
Link
United States of America
GERMANTOWN